Laboratory Testing for Direct Bilirubin

Understanding Direct Bilirubin Testing

The American Academy of Pediatrics recommends measuring direct bilirubin as part of a comprehensive bilirubin panel that includes both total and direct (conjugated) bilirubin measurements in patients with jaundice 1, 3
The direct bilirubin fraction includes both conjugated bilirubin and delta bilirubin (which is bound to albumin) in individuals with liver disease 3, 4
This test is particularly important for identifying cholestasis and differentiating between different causes of hyperbilirubinemia in newborns 1, 5

The American Academy of Pediatrics recommends direct bilirubin testing for jaundice present at or beyond 3 weeks of age in infants 1, 2
Sick infants with jaundice should undergo direct bilirubin testing to evaluate for sepsis or other underlying conditions 1, 6
Infants receiving phototherapy or with rapidly rising total serum bilirubin (TSB) levels should be tested for direct bilirubin to assess the need for exchange transfusion 2, 5
The European Association for the Study of the Liver recommends direct bilirubin testing for suspected cholestatic liver disease in adults and children 3, 4
The American Association for the Study of Liver Diseases recommends direct bilirubin testing for evaluation of drug-induced liver injury (DILI) in patients with elevated liver enzymes 3, 4

In drug-induced liver injury, the direct bilirubin fraction is usually greater than 35% of the total bilirubin, according to the American Association for the Study of Liver Diseases 4
In Gilbert's syndrome (a benign condition), conjugated bilirubin should be less than 20-30% of the total bilirubin, as recommended by the European Association for the Study of the Liver 4, 7
When evaluating jaundiced infants, it's essential to interpret bilirubin levels according to the infant's age in hours, as recommended by the American Academy of Pediatrics 5, 8

The American Academy of Pediatrics recommends against subtracting direct bilirubin from total bilirubin when making clinical decisions about phototherapy or exchange transfusion in newborns 9
In cases where direct bilirubin is 50% or more of the total bilirubin, consultation with a specialist is recommended by the American Association for the Study of Liver Diseases 9
If the etiology of prolonged hyperbilirubinemia is uncertain, consider requesting a breakdown of the direct bilirubin fraction into conjugated and delta bilirubin components, as recommended by the European Association for the Study of the Liver 4, 7

For elevated direct bilirubin in infants, the American Academy of Pediatrics recommends performing urinalysis, urine culture, and evaluating for sepsis if clinically indicated 1, 8
For jaundice at or beyond 3 weeks, check results of newborn thyroid and galactosemia screening, as recommended by the American Academy of Pediatrics 1, 2
For suspected cholestatic liver disease, evaluate for causes of cholestasis, according to the European Association for the Study of the Liver 1, 3
For suspected drug-induced liver injury, monitor liver function tests and consider drug interruption, as recommended by the American Association for the Study of Liver Diseases 3, 4